Related references
Note: Only part of the references are listed.Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
Jonathan M. Kocarnik et al.
JAMA ONCOLOGY (2022)
Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort
Guillaume Beinse et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Drug-Related Problems and Pharmacist Intervention at a General Hospital in the Jazan Region, Saudi Arabia
Salmeen D. Babelghaith et al.
RISK MANAGEMENT AND HEALTHCARE POLICY (2020)
A computational approach to predict multi-pathway drug-drug interactions: A case study of irinotecan, a colon cancer medication
Abdullah Assiri et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
Dominique A. Garrison et al.
PHARMACEUTICS (2020)
Role of the mechanical microenvironment in cancer development and progression
Qiuping Liu et al.
CANCER BIOLOGY & MEDICINE (2020)
Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay
Lydia Sanchez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Drug-Drug Combinations Can Enhance Toxicity as Shown by Monocyte-Derived Hepatocyte-like Cells From Patients With Idiosyncratic Drug-Induced Liver Injury
Andreas Benesic et al.
TOXICOLOGICAL SCIENCES (2019)
Cancer Incidence Trends From 1999 to 2015 And Contributions Of Various Cancer Types To The Overall Burden: Projections To 2030 And Extrapolation Of Economic Burden In Saudi Arabia
Abdul Rahman Jazieh et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions
Peter Stopfer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics
Lauren A. Marcath et al.
Journal of Oncology Practice (2018)
A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation
Jessica E. Ericson et al.
THERAPEUTIC DRUG MONITORING (2017)
Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance
Allan Ramos-Esquivel et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
John B. Bossaer et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
R. W. F. van Leeuwen et al.
ANNALS OF ONCOLOGY (2015)
A pilot study on the impact of known drug-drug interactions in cancer patients
Silvia Ussai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Drug-drug interaction software in clinical practice: a systematic review
Tina Roblek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
An exploratory study investigating the potential drug-drug interactions in internal medicine department, Alahsa, Saudi Arabia
Yaser Albadr et al.
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH (2014)
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs
R. W. F. van Leeuwen et al.
BRITISH JOURNAL OF CANCER (2013)
Physicians' responses to computerized drug-drug interaction alerts for outpatients
Min-Li Yeh et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2013)
Potential drug interactions and duplicate prescriptions among cancer patients
Rachel P. Riechelmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Drug interactions in cancer therapy
Charity D. Scripture et al.
NATURE REVIEWS CANCER (2006)
Physicians' decisions to override computerized drug alerts in primary care
SN Weingart et al.
ARCHIVES OF INTERNAL MEDICINE (2003)